#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute graft versus host disease in liver Cystic fibrosis Fibrodysplasia ossificans progressiva Alagille syndrome Diffuse large B-cell lymphoma refractory Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Infantile spasms Haemophilia Measles Familial hypertriglyceridaemia Neuropathic arthropathy Aspergillus infection Breast angiosarcoma Uterine leiomyosarcoma Craniopharyngioma More trials…

    Learn about Rare Diseases

    Congenital generalised lipodystrophy Progressive supranuclear palsy – Basic Information Nodal marginal zone B-cell lymphoma Prader-Willi syndrome – Treatment Richter’s syndrome – Life with Disease Lymphatic malformation – Life with Disease Alternating hemiplegia of childhood – Basic Information Ornithine transcarbamoylase deficiency – Trials in Disease Aicardi-Goutieres syndrome Antithrombin III deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abc-24F-116 Danicamtiv Agomelatine Azd3427 ULTEVURSEN Evx-01 AUROCELL-TX Triheptanoin Quinidine Sulfate Secukinumab Tertomotide Pyridoxine Hydrochloride Astegolimab GS-248 Atogepant Etravirine Pemetrexed Disodium Alizapride Pemetrexed Clomifene Citrate More therapies…

    Learn about Your Condition

    Graves' disease Short-bowel syndrome Neuroendocrine tumour PIK3CA-activated mutation Spinal cord injury Skin angiosarcoma Thrombocytosis Cirrhosis alcoholic Hydrocele Developmental hip dysplasia Tardive dyskinesia Bladder cancer stage II Autoimmune hepatitis Hyperglycaemia Lymphatic malformation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Phase 2 Study of PF-08634404 with Carboplatin and Etoposide in Adults with Untreated Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Etoposide
    France Italy Spain

  • Safety and Efficacy of MTX-474 in Adults with Diffuse Cutaneous Systemic Sclerosis (dcSSc) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Glucose Monohydrate
    • Sodium Chloride
    France Italy The Netherlands Poland Romania Spain

  • Phase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)

    Not yet recruiting

    3 1
    Belgium Bulgaria France Germany Greece Italy +4

  • Study of Short‑and Long‑Term Hemodynamic and Physiological Effects of Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Mavacamten
    Sweden

  • Study of venetoclax plus rituximab in adult patients with relapsed chronic lymphocytic leukemia (CLL) in Poland

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Rituximab
    • Venetoclax
    Poland

  • Safety of flecainide acetate compared with amiodarone hydrochloride and sotalol in patients with atrial fibrillation and stable coronary artery disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    • Atrial fibrillation
    Investigated Drugs:
    • Sotalol
    • Amiodarone Hydrochloride
    • Flecainide Acetate
    Belgium
Previous Page
1 … 687 688 689 690 691 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!